Neonatal Diabetes Mellitus Due to Complete Glucokinase Deficiency

Pål R. Njølstad(Howard Hughes Medical Institute), Oddmund Sövik(Haukeland University Hospital), Antonio L. Cuesta‐Muñoz(University of Pennsylvania), Lise Bjørkhaug(Haukeland University Hospital), Ornella Massa(San Raffaele University of Rome), Fabrizio Barbetti(San Raffaele University of Rome), Dag E. Undlien, Chiyo Shiota(Vanderbilt University), Mark A. Magnuson(Vanderbilt University), Anders Molven(Haukeland University Hospital), Franz M. Matschinsky(University of Pennsylvania), Graeme I. Bell(Haukeland University Hospital)
New England Journal of Medicine
May 24, 2001
Cited by 428Open Access
Full Text

Abstract

Diabetes mellitus is a heterogeneous disorder that can occur at any age.1 Neonatal diabetes mellitus, defined as insulin-requiring hyperglycemia within the first month of life, is a rare disorder that is usually associated with intrauterine growth retardation.2 Like diabetes in general, neonatal diabetes is heterogeneous and can be either transient or permanent. Transient neonatal diabetes is associated with abnormalities of chromosome 6,2,3 whereas mutations in insulin promoter factor 1 result in pancreatic agenesis and permanent neonatal diabetes.4 We describe two patients in whom complete deficiency of the glycolytic enzyme glucokinase, a key regulator of glucose metabolism in pancreatic beta . . .


Related Papers

No related papers found

Powered by citation graph analysis